Validations: Serialization, Aggregation & Supply-Chain Data Integrity
Reject and Rework Flows: Physical vs Digital Alignment Reject and Rework Flows: Physical vs Digital Alignment Introduction to Serialization and Aggregation in Pharmaceuticals The implementation of serialization and aggregation processes is paramount for pharmaceutical companies aiming to comply with various regulatory standards, such as the DSCSA in the United States, and the EU FMD requirements. These regulatory frameworks ensure that…
Line Clearance and Reset Controls Line Clearance and Reset Controls in Pharmaceutical Validation The pharmaceutical industry mandates stringent qualification processes to ensure compliance with regulatory guidelines and maintain data integrity. This article offers a step-by-step tutorial on designing effective line clearance and reset controls related to serialization, aggregation, and reconciliation processes. The focus will be on US FDA, EMA, and…
Line Clearance and Reset Controls Line Clearance and Reset Controls Introduction to Line Clearance and Reset Controls In the highly regulated environment of pharmaceutical manufacturing, ensuring that production lines are free from contamination between batches is paramount. This practice is commonly referred to as line clearance and reset controls. These controls are not only vital in maintaining product integrity but…
Aggregation at Speed: Throughput vs Readability Aggregation at Speed: Throughput vs Readability In the competitive pharmaceutical landscape, the effective management of serialization and aggregation initiatives is critical to ensuring compliance and enhancing supply-chain integrity. As regulatory requirements continue to evolve, pharmaceutical organizations must emphasize effective qualification of serialization systems. This article serves as a comprehensive step-by-step tutorial on designing a…
Aggregation at Speed: Throughput vs Readability Aggregation at Speed: Throughput vs Readability Introduction to Serialization and Aggregation in Pharmaceuticals The pharmaceutical industry is currently navigating a complex regulatory environment that mandates adherence to serialization and aggregation guidelines. These processes ensure traceability and integrity of medications throughout the supply chain, a requirement emphasized by various regulatory authorities such as the FDA,…
Sampling Plans for Reconciliation Verification Sampling Plans for Reconciliation Verification Introduction to Sampling Plans and Reconciliation Verification In the pharmaceutical landscape, serialization and aggregation have become imperative for compliance with regulations such as the Drug Supply Chain Security Act (DSCSA) in the United States and the European Falsified Medicines Directive (EU FMD) in the EU. Properly designed sampling plans for…
Sampling Plans for Reconciliation Verification in Pharmaceutical Serialization and Aggregation Introduction to Sampling Plans The implementation of sampling plans for reconciliation verification is essential in the pharmaceutical industry, particularly for ensuring compliance with serialization and aggregation requirements. These plans play a crucial role in validating interfaces between systems, conducting line and level qualifications, and maintaining master data governance. This guide…
Mixed-Product/Multi-Market Runs: Controls That Work Mixed-Product/Multi-Market Runs: Controls That Work In the evolving landscape of pharmaceutical manufacturing, serialization and aggregation have emerged as critical components for supply-chain integrity and compliance within regulatory frameworks such as the US FDA Drug Supply Chain Security Act (DSCSA), the EU Falsified Medicines Directive (FMD), and guidelines from the MHRA and PIC/S. This tutorial provides…
Mixed-Product/Multi-Market Runs: Controls That Work Mixed-Product/Multi-Market Runs: Controls That Work Introduction to Mixed-Product/Multi-Market Runs in the Pharmaceutical Industry The complexity in pharmaceutical production often necessitates mixed-product or multi-market runs. This is particularly prevalent in systems designed for serialization, aggregation, and ensuring compliance with regulatory guidelines such as the Drug Supply Chain Security Act (DSCSA) in the U.S. and corresponding European…
KPIs for Interface Health and Data Completeness Introduction to Serialization and Aggregation In the pharmaceutical industry, ensuring data integrity is of paramount importance, particularly in serialization and aggregation processes. These processes are essential for compliance with stringent regulations such as the Drug Supply Chain Security Act (DSCSA) in the United States and the European Falsified Medicines Directive (EU FMD) in…